image

The best stocks to buy since 1993

Latest issue now available

Creston - Two acquisitions expected by year end

July 2002

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CRG
During the month we met again with Creston's (50p) chief executive, Don Elgie, following release of  results for the year to 31 March, the first since Creston's relaunch as a "buy and build" marketing services business. Creston has completed two acquisitions to date. Based on a full year from Marketing Sciences and four months from Real Adventure, profit before tax was £207,000 after deducting head office costs of £559,000. Sales were £9.8m and net cash at the period end was £1.9m. Investors have, understandably, become so cautious about anything even vaguely related to advertising that they may be missing the investment potential in Creston which is a relatively rare commodity as a pure marke ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe